Delhivery Limited has announced an analyst meet scheduled for April 15, 2026, at its Lonad Mega Gateway facility in Bhiwandi, Maharashtra. The company filed this regulatory intimation on April 9, 2026, under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details and Compliance

The logistics company will host a group of analysts at its Bhiwandi facility on Wednesday, April 15, 2026. The meeting represents part of Delhivery's ongoing engagement with the investment community to provide insights into its operations and business outlook.

Information Disclosure Framework

Delhivery has emphasized strict adherence to regulatory guidelines regarding information sharing during the analyst interaction. The company has clearly stated that no unpublished price sensitive information will be disclosed during the meeting, ensuring compliance with market regulations.

The discussion agenda will focus on:

• General business outlook
• Information already available in the public domain
• Operational insights within regulatory boundaries

Regulatory Compliance and Transparency

The intimation was signed by Madhulika Rawat, Company Secretary & Compliance Officer (Membership No: F8765), and digitally authenticated on April 9, 2026, at 15:45:38 +05'30'. The company has also uploaded this disclosure on its official website at www.delhivery.com , ensuring broader accessibility to stakeholders.

This analyst meet reflects Delhivery's commitment to maintaining transparent communication with the investment community while adhering to regulatory requirements. The choice of the Lonad Mega Gateway facility in Bhiwandi provides analysts with direct exposure to the company's logistics infrastructure and operational capabilities.

Delhivery Limited has completed the allotment of 86,225 equity shares following the exercise of vested employee stock options, as approved by the company's Stakeholders' Relationship Committee on April 08, 2026. The allotment was conducted in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Share Allotment Details

The total allotment of 86,225 equity shares was distributed across two employee stock option plans:

All shares carry a face value of Re. 1/- each and are fully paid-up. The newly allotted equity shares rank pari-passu with the existing equity shares of the company in all respects.

Exercise Pricing Structure

The options were exercised at varying price points across the two schemes:

The total money realized through the exercise of these options amounted to Rs. 4,85,177.85/-.

Impact on Share Capital

Following this allotment, the company's paid-up share capital has increased:

The diluted earnings per share calculation is based on the company's Q3FY26 earnings report.

Regulatory Compliance

The share allotment adheres to SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The options vest according to schedules determined by the Nomination and Remuneration Committee, with vested options exercisable at any time from their respective vesting dates as per grant terms.

Key features of the ESOP schemes include provisions for handling options in cases of employee death, resignation, or termination, and automatic adjustments for corporate actions such as rights issues or bonus issues. The allotted shares are not subject to any lock-in restrictions and carry full voting and dividend rights equivalent to existing equity shares.